BPMC - Blueprint Medicines GAAP EPS of $1.40 beats by $3.05 revenue of $96.12M beats by $14.68M
2024-05-02 07:09:41 ET
More on Blueprint Medicines
- Blueprint Medicines: Ayvakit Revenue Surge Fuels Optimism (Rating Upgrade)
- Blueprint Medicines Corporation (BPMC) Q4 2023 Earnings Call Transcript
- Blueprint Medicines Q1 2024 Earnings Preview
- Blueprint Medicines Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Blueprint Medicines